The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin, Donald P
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. [electronic resource] - The American journal of medicine Oct 2006 - 63-72 p. digital
Publication Type: Journal Article; Review
1555-7162
10.1016/j.amjmed.2006.08.009 doi
Acute Disease
Adrenal Cortex Hormones--therapeutic use
Adrenergic beta-Agonists--therapeutic use
Aged
Albuterol--analogs & derivatives
Androstadienes--therapeutic use
Bronchodilator Agents--therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Dyspnea--etiology
Female
Fluticasone
Forced Expiratory Volume--drug effects
Health Status
Humans
Male
Middle Aged
Patient Admission
Patient-Centered Care
Pulmonary Disease, Chronic Obstructive--drug therapy
Quality of Life
Randomized Controlled Trials as Topic
Research Design
Risk Assessment
Risk Factors
Salmeterol Xinafoate
Scopolamine Derivatives--therapeutic use
Severity of Illness Index
Tiotropium Bromide
Treatment Outcome
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. [electronic resource] - The American journal of medicine Oct 2006 - 63-72 p. digital
Publication Type: Journal Article; Review
1555-7162
10.1016/j.amjmed.2006.08.009 doi
Acute Disease
Adrenal Cortex Hormones--therapeutic use
Adrenergic beta-Agonists--therapeutic use
Aged
Albuterol--analogs & derivatives
Androstadienes--therapeutic use
Bronchodilator Agents--therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Dyspnea--etiology
Female
Fluticasone
Forced Expiratory Volume--drug effects
Health Status
Humans
Male
Middle Aged
Patient Admission
Patient-Centered Care
Pulmonary Disease, Chronic Obstructive--drug therapy
Quality of Life
Randomized Controlled Trials as Topic
Research Design
Risk Assessment
Risk Factors
Salmeterol Xinafoate
Scopolamine Derivatives--therapeutic use
Severity of Illness Index
Tiotropium Bromide
Treatment Outcome